Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

  • There is currently no data for CRL

Directorate Change

7 Mar 2024 07:00

RNS Number : 8981F
Creightons PLC
07 March 2024
 

7 March 2024 

 

CREIGHTONS plc ("Creightons" or the "Company")

Board Changes

and New Appointment

 

Creightons plc (LSE: CRL), product developers, brand owners and manufacturers of personal care, beauty, and fragrance products, announces the following changes to the Board of directors, all of which take place with immediate effect.

Ms Philippa Clark has been appointed as Group Managing Director. Pippa has been Global Sales and Marketing Director and a member of the Board since 2015. Pippa has been integral in driving the organic sales growth over the past 20 years, has an intimate knowledge of the business, its customers and the market in which it operates. Pippa has also been key in the ideation, development and launch to market of a number of the company's brands. This experience places her in a unique position to lead the business forward for the foreseeable future. Pippa will continue to be supported by Martin Stevens in his executive director role as Group Deputy Managing Director.

Mr William McIlroy is retiring from his executive roles as Chairman and CEO. William will remain on the Board as a non-executive director, which enables the Company to utilise the experience he has gained over the past 24 years.

Mr Paul Forster, currently a non-executive director having retired from his Executive role as Finance Director in 2021, will take over as the non-executive Chair of the Board. Paul's knowledge of the business, the executive directors and senior team members will help the company navigate the changes needed to move the Group forward.

Mr Brian Geary has joined the board as a non-executive director. Brian has a wide experience in business and as an investor in small, quoted businesses to include Creightons plc. This will enable the Company to benefit from Brian's knowledge to create shareholder value. 

Mr Geary's current and past directorships (within the last 5 years) are as follows:

Current: Antrim Hills Spring Water Company Limited

Past: Port Saffron Limited

There is no further information on Mr Geary required to be disclosed under LR 9.6.13.

Mr Geary and his family currently hold a total of 7,043,259 ordinary shares in the Company, representing a holding of 10.29 %.

Quote

''I and my board colleagues would like to thank William McIlroy for his service and insightful contribution to the business over the past 24 years and to welcome Brian Geary to the Board. We would also like to thank Pippa Clark, Martin Stevens and the executive management team for their work guiding the company over the past few months and look forward to working with them as they develop a new focus on driving sales and profit growth.''

Paul Forster, Chair of the Board

Creightons plc.

Enquiries analysts/investors email info@creightons.com

Roland Cornish, Beaumont Cornish Limited 0207 628 3396

 

Beaumont Cornish Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is Financial Adviser to the Company in relation to the matters referred herein. Beaumont Cornish Limited is acting exclusively for the Company and for no one else in relation to the matters described in this announcement and is not advising any other person and accordingly will not be responsible to anyone other than the Company for providing the protections afforded to clients of Beaumont Cornish Limited, or for providing advice in relation to the contents of this announcement or any matter referred to in it.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAQKABBFBKDCNK
Date   Source Headline
2nd Sep 20208:25 amRNSPreliminary Results Presentation
2nd Sep 20207:00 amRNSPreliminary Results
25th Aug 202010:31 amRNSUpdate - publication of preliminary results
24th Aug 20202:00 pmRNSPrice Monitoring Extension
8th Jul 20208:58 amRNSDirector update and grants of share options
8th Jul 20208:56 amRNSUpdate on preliminary results
26th May 20209:42 amRNSHolding(s) in Company
13th May 20204:41 pmRNSSecond Price Monitoring Extn
13th May 20204:37 pmRNSPrice Monitoring Extension
11th May 202011:05 amRNSSecond Price Monitoring Extn
11th May 202011:00 amRNSPrice Monitoring Extension
3rd Apr 20204:40 pmRNSSecond Price Monitoring Extn
3rd Apr 20204:35 pmRNSPrice Monitoring Extension
26th Mar 20202:05 pmRNSSecond Price Monitoring Extn
26th Mar 20202:00 pmRNSPrice Monitoring Extension
18th Mar 20209:39 amRNSBlock listing Interim Review
7th Feb 20204:54 pmRNSDirector/PDMR Shareholding
7th Feb 20209:06 amRNSSecond Price Monitoring Extn
7th Feb 20209:00 amRNSPrice Monitoring Extension
27th Jan 20201:05 pmRNSDirector/PDMR Shareholding
16th Jan 20206:06 pmRNSDirector shareholding, exercise of options, TVR
6th Jan 202011:47 amRNSDirector/PDMR Shareholding
28th Nov 20194:47 pmRNSMary Carney
20th Nov 20199:05 amRNSSecond Price Monitoring Extn
20th Nov 20199:00 amRNSPrice Monitoring Extension
20th Nov 20197:00 amRNSInterim Financial Report
11th Nov 20193:32 pmRNSInterim Results Presentation
10th Oct 20192:03 pmRNSResult of Meeting
20th Sep 20191:22 pmRNSProperty purchase agreement, Circular publication
18th Sep 20197:00 amRNSBlock Listing Six Monthly Return
14th Aug 20191:05 pmRNSResult of AGM
27th Jun 20195:29 pmRNSReport & Accounts, AGM, Final Dividend Declaration
26th Jun 201911:05 amRNSSecond Price Monitoring Extn
26th Jun 201911:00 amRNSPrice Monitoring Extension
26th Jun 20197:00 amRNSPreliminary Results
25th Jun 201911:54 amRNSAcquisition of Balance Active Formula
20th Jun 20193:52 pmRNSFull Year 2019 Results Presentation
20th Jun 20197:00 amRNSFull Year 2019 Results Presentation
17th May 20197:00 amRNSFinal results timetable and trading update
1st May 20194:43 pmRNSDirector/PDMR Shareholding
1st Apr 20194:52 pmRNSIssue of Equity and TVR
28th Mar 20195:06 pmRNSDirector/PDMR Shareholding
19th Mar 20192:14 pmRNSReplacement: Listing Application
13th Mar 20195:04 pmRNSListing Application
25th Feb 20193:26 pmRNSChange of Auditor
14th Feb 20192:16 pmRNSChange of Auditor
20th Dec 20183:57 pmRNSDirector/PDMR Shareholding
10th Dec 201812:26 pmRNSExercise of share options
29th Nov 201812:45 pmRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.